ProBioGen announced today that they have entered into a research license agreement with Heat Biologics for both ProBioGen's Transposase System DirectedLuck™ as well as for their proprietary suspension HEK293 cell line.
Despite being most at risk from Covid-19, older people and those with compromised immune systems are unlikely to reap much benefit from Covid-19 vaccines, which are the main way we can overcome the viral pandemic.